Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America.
School of Global Public Health, New York University, New York, NY, United States of America.
PLoS One. 2024 Feb 29;19(2):e0299834. doi: 10.1371/journal.pone.0299834. eCollection 2024.
We assessed longitudinal effects of e-cigarette use on respiratory symptoms in a nationally representative sample of US adults by combustible tobacco smoking status.
We analyzed Waves 4-5 public-use data from the Population Assessment of Tobacco and Health Study. Study sample included adult respondents who reported no diagnosis of respiratory diseases at Wave 4, and completed Waves 4-5 surveys with no missing data on analytic variables (N = 15,291). Outcome was a validated index of functionally important respiratory symptoms based on 7 wheezing/cough questions (range 0-9). An index score of ≥2 was defined as having important respiratory symptoms. Weighted lagged logistic regression models were performed to examine the association between e-cigarette use status at Wave 4 (former/current vs. never use) and important respiratory symptoms at Wave 5 by combustible tobacco smoking status (i.e., never/former/current smokers), adjusting for Wave 4 respiratory symptom index, sociodemographic characteristics, secondhand smoke exposure, body mass index, and chronic disease.
Among current combustible tobacco smokers, e-cigarette use was associated with increased odds of reporting important respiratory symptoms (former e-cigarette use: adjusted odds ratio [AOR] = 1.39, 95% confidence interval [CI]: 1.07-1.81; current e-cigarette use: AOR = 1.55, 95% CI: 1.17-2.06). Among former combustible tobacco smokers, former e-cigarette use (AOR = 1.51, 95% CI: 1.06-2.15)-but not current e-cigarette use (AOR = 1.59, 95% CI: 0.91-2.78)-was associated with increased odds of important respiratory symptoms. Among never combustible tobacco smokers, no significant association was detected between e-cigarette use and important respiratory symptoms (former e-cigarette use: AOR = 1.62, 95% CI: 0.76-3.46; current e-cigarette use: AOR = 0.82, 95% CI: 0.27-2.56).
The association between e-cigarette use and respiratory symptoms varied by combustible tobacco smoking status. Current combustible tobacco smokers who use e-cigarettes have an elevated risk of respiratory impairments.
我们通过评估可燃烟草吸烟状况,评估了电子烟使用对美国成年人呼吸症状的纵向影响。
我们分析了来自人口烟草与健康评估研究的第 4-5 波公开使用数据。研究样本包括在第 4 波时报告没有呼吸道疾病诊断且完成了第 4-5 波调查且分析变量无缺失数据的成年受访者(N=15291)。结果是根据 7 个喘息/咳嗽问题(范围 0-9)得出的功能重要性呼吸症状的有效指数。将指数评分≥2 定义为有重要的呼吸症状。采用加权滞后逻辑回归模型,根据可燃烟草吸烟状况(即从不吸烟者/前吸烟者/当前吸烟者),检验第 4 波时电子烟使用状况(前电子烟使用者/当前电子烟使用者与从不使用者)与第 5 波时重要呼吸症状之间的关联,调整第 4 波呼吸症状指数、社会人口特征、二手烟暴露、体重指数和慢性疾病。
在当前可燃烟草吸烟者中,电子烟使用与报告有重要呼吸症状的几率增加相关(前电子烟使用者:调整后的比值比[OR] = 1.39,95%置信区间[CI]:1.07-1.81;当前电子烟使用者:OR = 1.55,95% CI:1.17-2.06)。在曾经使用可燃烟草的吸烟者中,前电子烟使用(OR = 1.51,95% CI:1.06-2.15)-而非当前电子烟使用(OR = 1.59,95% CI:0.91-2.78)-与重要呼吸症状几率增加相关。在从不使用可燃烟草的吸烟者中,电子烟使用与重要呼吸症状之间没有明显关联(前电子烟使用者:OR = 1.62,95% CI:0.76-3.46;当前电子烟使用者:OR = 0.82,95% CI:0.27-2.56)。
电子烟使用与呼吸症状之间的关联因可燃烟草吸烟状况而异。目前使用可燃烟草并使用电子烟的吸烟者有呼吸受损的风险增加。